Daily Maverick
Dailymaverick logo

South Africa

South Africa, Maverick Citizen

Access, not excess, is key to reducing antibiotic resistance in SA - experts

Access, not excess, is key to reducing antibiotic resistance in SA - experts
Tiyese Jeranji for Spotlight
By Tiyese Jeranji for Spotlight
12 Dec 2022
Facebook
0
We spoke to experts about antimicrobial resistance, and all agreed that we should use far less antibiotics and only use them when they are absolutely necessary. But actually making this happen is surprisingly complex.

Antibiotics play a vital role in the management of bacterial infections, reducing morbidity, and preventing mortality. A 2011 report from the UK estimated that they have increased life expectancy by 20 years. However, the extensive use of antibiotics has resulted in drug resistance that threatens to reverse their life-saving power — if the situation is not reversed, it has been estimated that by 2050, 10 million people will die annually of drug-resistant infections.  

Such estimates of future deaths are obviously uncertain, but there is strong evidence the problem is already very serious. A major study published earlier this year in the Lancet estimated that globally about 1.27 million deaths in 2019 were directly due to antibiotic resistance. The study identified Sub-Saharan Africa as the hardest-hit region. 

What is AMR? 


Sham Moodley, a community pharmacist from Durban and the vice-chairperson of the Independent Community Pharmacy Association explains that antimicrobial resistance (AMR) is the ability of microorganisms (bacteria, viruses, fungi, and protozoa) to withstand treatment with antimicrobial drugs. 

“It is vitally important as it directly impacts our ability to treat and cure common infectious diseases, including pneumonia, urinary tract infections, gonorrhoea and tuberculosis,” he says.  

According to Professor Olga Perovic, principal pathologist at the National Institute of Communicable Diseases’ Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, there are six factors fuelling the AMR crisis. 

These are:

  • Overprescribing and dispensing of antibiotics by health workers;

  • Patients not finishing their full treatment course of antibiotics;

  • Poor infection control in hospitals and clinics;

  • Lack of hygiene and poor sanitisation in the community,

  • Lack of new antibiotics being developed; and

  • The overuse of antibiotics in livestock and fish farming. 


Under overuse, she stresses the misuse of antibiotics to treat upper respiratory tract infections, which are typically viral rather than bacterial. Antibiotics are powerless against viruses. Another driver of inappropriate or overprescribing of antibiotics, she says, may be the lack of testing of specimens for the presence of bacteria and their susceptibility to treatment. 

How can we prevent AMR? 


Dr Marc Mendelson, a professor of infectious diseases and head of the Division of Infectious Diseases and HIV Medicine at Groote Schuur Hospital, the University of Cape Town as well as the chairperson of the Ministerial Advisory Committee on Antimicrobial Resistance, says reducing the use of antibiotics is about preventing the need for a prescription in the first place. (Mendelson’s recent SAMJ article provides excellent further reading on AMR in South Africa.) 

“So, reducing the burden of infections through the provision of clean water and safe sanitation (reduces diarrhoeal diseases) and vaccination programmes (reduces diarrhoea and pneumonia for instance),” he says. “Education and awareness raising of the public and (sadly) healthcare professionals as to the correct use of antibiotics is also critical.”  

Broadly speaking, all the experts we interviewed agreed that we should use far less antibiotics and only use them when they are absolutely necessary. But actually making this happen is surprisingly complex. 

Part of the complexity, for example, is that resistance profiles and disease profiles are different in different places. Geraldine Turner, a pharmacist at Knysna Hospital in the Western Cape, says there is a need for guidelines tailored to the South African context or linked to the local epidemiology. This, she says, can play an important role in determining the correct antibiotics to be used. 

It is also not just an issue of what antibiotics are prescribed for humans. 

“A big driver of antimicrobial resistance is overuse in agriculture,  and collaboration with stakeholders in this regard is required,” says Turner. She says we need policies that facilitate improved integration among environmental, animal, and human sector interventions. 

Moodley agrees that a multidisciplinary, One Health approach is needed at every level of care and in human and animal health sectors. 

“It is important we reinforce the principle that antimicrobial medicines for human use are only supplied on the authority of a healthcare professional and that antimicrobial medicines for either human or animal use are only supplied in accordance with country legislation and regulations,” he says.  



Visit Daily Maverick's home page for more news, analysis and investigations



The role of stewardship programmes 


One response to the AMR crisis is antimicrobial stewardship programmes or ASPs. Moodley describes ASPs as a systematic approach used “to optimise appropriate use of all antimicrobials to improve patient outcome and limit emergence of resistant pathogens whilst ensuring patient safety”. 

Perovic says, “In healthcare institutions, resistant bacteria can spread easily within and from patient to patient. That is why there are guidelines, which we call ASPs, in the medical and veterinary fields, on how and when antibiotics are prescribed as well as how to implement infection prevention and control measures, particularly for patients with health risks such as diabetes, high blood pressure and cancer.” 

“In hospitals,” explains Mendelson, “ASPs will consist of a governance body such as an AS Committee that directs a work programme of stewardship, often with AS teams as the implementers of policy. AS teams can involve anything from single pharmacists or physicians, through one to two dedicated individuals, through to all-singing,  all-dancing, multidisciplinary teams in academic teaching hospitals, comprising infectious diseases specialists, microbiologists, pharmacists, [and] infection prevention and control nurses.” 

ASPs are not only important at institutional levels, adds Moodley, but imperative for every individual prescriber/practitioner to implement to reduce AMR in our population.  

Critical role for pharmacists 


Mendelson stresses that pharmacists are integral to antibiotic stewardship in South Africa and globally. 

“Community pharmacists give advice to patients seeking symptomatic relief and reduce doctors’ visits, which can result in antibiotic prescriptions when not needed,” he says. In hospitals, dispensing pharmacists help optimise the antibiotics prescribed to patients by checking indications for the antibiotic, dose, dosing frequency and duration. 

“Some hospitals have pharmacists on the wards, again, checking and helping to optimise the use of antibiotics,” he says. 

“Pharmacists play an important role in recommending symptomatic treatments for non-specific symptoms and particularly, the common cold, which is a major cause of inappropriate antibiotic prescribing, requiring simple paracetamol with or without decongestants. Unfortunately, a recent pilot study suggests that a small number of community pharmacies are dispensing antibiotics without a prescription, which is not allowed in South Africa,” says Mendelson. 

Turner concurs that pharmacists play a crucial role in ensuring the correct antibiotics are used appropriately, only if indicated. She says pharmacists are also in a good position to counsel and advise patients on the correct use of antibiotics.    

Strategy framework 


The key policy document setting out South Africa’s response to AMR is the South Africa Antimicrobial Resistance Strategy Framework of 2018-2024. The framework outlines nine strategic objectives — they include:

  • Improving the appropriate use of diagnostic investigations to identify pathogens;

  • Guiding patient and animal management and ensuring good quality laboratory tests;

  • Enhancing infection prevention and control;

  • Promoting appropriate use of antimicrobials in humans and animals; and

  • Legislative and policy reform to strengthen health systems. 


Mendelson is positive about what has been achieved so far. 

“There have been major improvements to the surveillance and reporting of antibiotic resistance and antibiotic use in humans and animals, development of a greater One Health (human, animal and environmental health) response. 

“There was a formation of national training centres for antibiotic stewardship and empowerment of under-resourced provinces to train and develop Antimicrobial Stewardship programmes and there have been improvements in governance and delivery of infection prevention and control measures in hospitals and development of education programmes for healthcare workers in South Africa,” he says.  

But Mendelson says challenges remain in promoting behaviour change among the health workforce in SA and the expectations and social position that antibiotics hold in society. 

As with several other health policies, there are questions on whether the plan has been backed up with funding. 

“The national strategic framework remains largely unfunded (shared by most low- and middle-income countries), but this does hamper progress in developing programmes of interventions,” says Mendelson. 

“In food production, reducing [the] use of antibiotics is an important goal but will require investment in reducing drivers of infection in the animals that produce food. Legislation to bring all antibiotic prescribing in food production under veterinarian control will be an important intervention,” says Mendelson. DM/MC

This article was published by Spotlight – health journalism in the public interest.

Spotlight logo

Categories:

Tags: